Human neuroblastoma cells often carry amplified DNA encompassing the gene N-myc. Amplified N-myc has been found localized in "double minutes" in direct tumor cell preparations. In contrast, later passages carried amplified N-myc almost exclusively within a single homogeneously staining chromosomal region located at a chromosomal site different from the normal location of N-myc. We used pulsed field gel electrophoresis to define the structural arrangement of the amplified DNA. Long-range mapping was facilitated by the presence of several sites for rare cutting restriction endonucleases in the 5' region of N-myc. Amplified DNAs of different neuroblastoma cell lines were heterogeneous in size and had undergone recombination at various distances from N-myc. N-myc occupied a central position within the amplified DNA, and in no case was the coding region affected by recombination. Among neuroblastoma cells, varying proportions of amplified DNA (in some instances close to 100%) consisted of multiple tandem arrays of DNA segments ranging in size from 100 to 700 kilobase pairs. Tumor cells with low degrees of amplification revealed regions of amplified DNA in excess of 1,500 kilobase pairs without apparent rearrangement. Our observations, in concert with the cytogenetic findings, suggest a model of gene amplification which involves unscheduled DNA replication, recombination, and formation of extrachromosomal DNA followed by integration into a chromosome and subsequent in situ multiplication. The central position which N-myc occupies within the amplified sequences and the lack of recombination within the coding region of N-myc indicate that N-myc rather than other genetic information provides the selective advantage for retention of the amplified DNA.
DNA amplification represents a molecular mechanism by which the copy number of genes is selectively increased (for reviews, see references 23 and 34) . Originally discovered in the context of drug resistance, amplification has turned out to be a frequent genetic change of human and animal tumor cells not exposed previously to cytotoxic drugs (for a review, see reference 1). The first indications of the presence of amplified DNA in tumor cells were in cytogenetic studies that revealed the chromosomal abnormalities "double minutes" (DMs) and "homogeneously staining chromosomal regions" (HSRs), which are diagnostic for amplified DNA. Over the past years, it has emerged that, in many cases, amplified DNA in tumor cells contains multiple copies of cellular oncogenes (for reviews, see references 1 and 24) . While most types of tumors appear to carry amplification of cellular oncogenes only sporadically, some human tumor types are characterized by frequent amplification of a particular gene. Instances include the gene N-myc in neuroblastoma (16) and ERBB2/HER in mammary (31) cancers.
The DNA amplified in tumor cells spans a region far beyond the confines of a particular cellular oncogene. Most information about the structure and complexity of amplified DNA in tumor cells is from studies of amplified N-myc in neuroblastoma cells. The complexity of the amplified DNA in neuroblastoma cells has been estimated to range up to 3,000 kilobase pairs (kbp) in cell line IMR-32 (14) , although considerably lower values of around 200 kilobases have been reported for several other neuroblastoma cell lines (15) . Studies involving random sequences isolated from amplified DNA by competitive reassociation techniques have revealed that the complexities of the amplified DNA differ among neuroblastoma cell lines established from tumors from dif-* Corresponding author. ferent patients (30) . Further, the gene N-myc appeared to map to a core region commonly amplified in all neuroblastoma cells analyzed (30) .
Assessment of the possible role that the amplified N-myc gene might have in tumorigenesis has been hampered by the difficulty of determining whether additional transcription units are present in the amplified DNA. A further evaluation of the possible contribution of N-myc to development of neuroblastoma requires an understanding of the structure and of transcription units present in the amplified DNA. It appears reasonable to address these questions by using tumor cells in which the complexity of the amplified DNA is low and therefore more amenable to structural and functional analyses. We have directly analyzed the structure and size of amplified DNA encompassing N-myc by pulsed field gel electrophoresis (PFGE). This technique allows separation of DNA fragments up to several thousand kilobase pairs (for a review, see reference 3) , and in combination with rare cutting restriction endonucleases, the topography of large genomic regions can be directly defined. The recognition sequences for rare cutting restriction endonucleases are usually spaced several hundred kilobase pairs apart and are often clustered in regions referred to as CpG islands (6) . Our results show that the 5' region of N-myc contains recognition sequences for different rare cutting restriction endonucleases, allowing long-range mapping in both the 5' and 3' directions of N-myc. The sizes of the amplified DNA in different neuroblastoma cells vary from 100 to at least 1,500 kbp, with the simplest pattern of amplified DNA consisting of multiple head-to-tail tandem repeats in different neuroblastoma cells ranging from 100 kbp to several hundred. The structure of the amplified DNA remains stable through numerous passages of in vitro and in vivo cultivated cells. repetitions suggests a specific mechanism for DNA amplification.
MATERIALS AND METHODS
Southern blot analysis. For conventional Southern blot analysis, 10 ,ug of genomic DNA was digested with 40 U of enzyme. Size separation was performed by electrophoresis through agarose. Gels were treated with 0.25 M HCl for 25 min, and the DNA was denatured in 0.4 N NaOH-0.6 M NaCl for 30 min. After transfer of the DNA to Genescreenplus (Dupont, NEN Research Products), the membranes were neutralized with 0.05 M NaPO4 (pH 7.2)-2x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate) and air dried. Prehybridization was at 68°C for at least 1 h in 7% sodium dodecyl sulfate-0.5 M NaPO4 (pH 7.2). Hybridization was done at 68°C for 24 h with 2 x 106 to 4 x 106 cpm of randomly primed 32P-labeled DNA per ml. Washing was at room temperature for 15 min in 1% sodium dodecyl sulfate-40 mM NaPO4 (pH 7.2) followed by two 20-min washes at 68°C in the same solution. Exposure was for 6 h to 5 days. After removal of the probe, filters were reused by boiling for 20 to 30 min wo 0.1x SSC-1% sodium dodecyl sulfate and washing for 3 min in 40 mM NaPO4 at room temperature. PFGE gels were analyzed identically.
PFGE. High-molecular-weight DNA from cultured cells or from cells directly isolated by trypsinization from tumor tissue was prepared in agarose plugs. A suspension of single cells was adjusted in phosphate-buffered saline to a concentration that depended on degree of amplification. Cell lines carrying >80 copies of N-myc were prepared to a concentration of 2.0 x 106; cells with lower amplification of N-myc were prepared up to 107. Cells without amplification were adjusted to 1.5 x 107. The cell suspension was mixed with an equal volume of molten 1% agarose (SeaPlaque; FMC Corp.) in phosphate-buffered saline poured into small molds and allowed to set into plugs of 100 ,ul each. The plugs were incubated at 50°C for 48 h in NDS (0.5 M EDTA, 0.01 M Tris hydrochloride, 1% Sarkosyl, pH 9.5) plus proteinase K (1 mg/ml) and washed three times for 2 h each with NDS at 4°C. Plugs were stored at 4°C. For restriction enzyme digestion, plugs were washed three times in TE at 4°C; each wash was 1 h. Restriction digests were carried out on one-half plug (50 ,ul) in a volume of 200 ,ul, using restriction buffer and incubation temperature recommended by the supplier. Digestion was performed for 4 to 6 h usually with 40 U of enzyme, with the exception of BssHII, which required 10 U. After incubation in 0.5x TBE-10 mM EDTA for 15 min, the plugs were directly loaded to the PFGE gel.
Size markers were oligomers of bacteriophage lambda c1857 DNA or chromosomes of Saccharomyces cerevisiae X21801 B (3) . PFGE was carried out in a Rotaphor apparatus (Bio-Rad Laboratories). The gel concentration was 1%. Electrophoresis was carried out in 0.5x TBE (0.0445 M Tris-borate, 0.0045 M boric acid, 0.001 M EDTA) at a temperature of 15°C for 48 h with the exception of that shown in Fig. 5 , which was run for 55 h. The angle of the electrodes was 1200. Running conditions were 9 V/cm and 65-s pulse in the experiments shown in Fig. 3 and 9 ; all others were run with a field strength of 9.75 V/cm and 70-s pulse time. With these conditions, the compression zone is located at a position equivalent to 1,200 to 1,400 kbp.
Cell culture. Cells were cultured in RPMI 1640 supplemented with 10% fetal calf serum. Lines HDN-3 and HDN-16 were established in our laboratory by Silke Bruderlein. Line SK-N-SH was from the American Type Culture Collection; NGP, NMB, and NLF were from Garrett Brodeur; CHP-126, CHP-134, and Kelly were from Fred Gilbert; and LS was from Rupert Handgretinger.
RESULTS
The 5' region of N-myc contains sites for rare cutting restriction endonucleases. Inspection of the DNA sequence of the 5' region of N-myc (17, 33) predicted the presence of sites for rare cutting restriction endonucleases, and DNA digestions confirmed these predictions ( Fig. 1 ; data not shown). Our studies showed that exon II of N-myc contains sites for the rare cutting restriction endonucleases MluI, BssHII, and NotI, the region 3' to exon I contains an additional BssHII, and the region 5' to exon I contains an MluI site. All sites were sensitive to digestion in DNA derived from both neuroblastoma cells and lymphocytes, which were analyzed for comparison (data not shown), and should serve as hallmarks for long-range mapping of the amplified DNA encompassing N-myc.
Long-range analysis of the N-myc locus. To determine the size range over which mapping of amplified DNA 5' and 3' of N-myc could be accomplished, we analyzed total DNA of in vitro cultivated lymphocytes derived from seven individuals. DNA was cut to completion with restriction endonuclease NotI or BssHII and fractionated by PFGE. The DNA was then transferred to a nylon filter. Molecular clones Nb-5 and Nb-12 ( Fig. 1 ) were used to detect the fragments flanking the recognition sites for NotI and BssHII in the 5' and the 3' direction, respectively. These clones will be referred to as 5' and 3' probes throughout this paper. All DNAs of lymphocytes yielded a 5' fragment about 400 kbp in size and a 3' fragment about 600 kbp in size with NotI ( Fig. 2 ). With BssHII, we again saw a 400-kbp 5' fragment. Towards Long-range analysis of N-myc locus. DNA of in vitro cultivated lymphocytes was digested as indicated and hybridized to probes located 5' (Nb-5) and 3' (Nb-12) to the restriction sites. Sizes of fragments were estimated by comparison with lambda oligomers and yeast chromosomes. additional 230-kbp BssHII fragment. The colocalization of Notl and BssHII recognition sites most likely defines regions 5' and 3' to N-myc that contain multiple sites for rare cutting restriction endonucleases. Digestion with MluI yielded an 820-kbp 5' fragment; in the 3' direction, the fragment was in the size range of 1,300 kbp. Recognition sites for the restriction endonuclease Sail could be determined by NotI-Sail double digests located 150 kbp in the 5' and 240 kbp in the 3' direction. A second 5' fragment at 380 kbp most likely was due to an incomplete SaiI digest. In our experience, Sail often cuts partially, independent of the amount of enzyme used. This is probably due to methylated Sail restriction sites. Altogether, restriction endonucleases Notl and BssHII allow analysis of the topography of up to 1,000 kbp of DNA around the N-myc locus; MluI enlarges this region to at least 2,000 kbp.
Amplified DNA often contains multiple rearrangements. We analyzed by PFGE the topography of the amplified DNA in 10 neuroblastoma cell lines carrying 25 to 140 copies of N-myc, using total genomic DNA digested with restriction endonuclease Notl (cell lines are indicated in Table 1 ). Inspection of the autoradiographs revealed complex patterns with either a 5' or a 3' probe, with as many as 10 bands in the 3' direction produced from DNA of cell line NGP ( Fig. 3 , left and right). In contrast, only one major fragment was seen for cell line IMR-32 when the 5' probe Nb-i was used. The size range of NotI fragments was 50 to 800 kbp, with the majority ranging from 150 to 600 kbp. With the exception of IMR-32, in none of these tumor cells were the normal 400-kbp 5' and 600-kbp 3' fragments predominant. This shows that, at least in most instances, the amplified DNA has undergone rearrangement within approximately 1,000 kbp around N-myc. We used two experimental approaches to find out that the complex band pattern was not due to incomplete digestion. First, increasing the amount of restriction endonuclease did not alter the banding pattern significantly, and second, double digestion of DNA with restriction endonucleases NotI and Sall did result in disappearance of Sall fragments (data not shown). We conclude that the amplified DNA differs in structure among the neuroblastoma cells tested and contains multiple rearrangements. Tandem arrangement of amplified DNA. DNA from nine cell lines revealed at least one NotI fragment that hybridized with both 5' and 3' probes. For instance, line NMB revealed three Notl fragments 200, 280, and 490 kbp in size with both 5' and 3' probes. In other cell lines, common 5' and 3' fragments were found within a size range of 100 to 700 kbp (see, for instance, HDN-16 and LAN-5, respectively; Fig. 3 , middle; solid bands denote common fragments). We thought it unlikely that the 5' and 3' probes in all instances detected different restriction fragments that comigrated. The pattern of detection, rather, conformed to tandem arrangement of amplified DNA, with each repeat unit containing only the NotI site within N-myc ( Fig. 4 ). The sizes of the amplified units would then be identical to the sizes of the respective Notl fragments (for instance, in line NMB, 200, 280, and 490 kbp). To analyze this interpretation in more detail, we used additional restriction endonucleases, BssHII and MIuI.
From NMB DNA, both enzymes generated restriction fragments that appeared to be identical when identified with 5' and 3' probes and of the same size as the NotI fragments ( Fig. 5 ). This observation confirms our model of a headto-tail tandem arrangement of amplified DNA of unit size. We analyzed DNA of three additional lines, HDN-16, Kelly, and NGP, with NotI, MluI, and BssHII. All three enzymes produced fragments of apparently identical size detectable with both 5' and 3' probes but varying among the lines ( signify regions containing sites for rare cutting restriction endonucleases that became located in the vicinity of N-myc by recombination. Alternatively, these restriction patterns could be due to a different type of regular DNA arrangement, such as inverted repetition. At present we cannot distinguish between these possibilities.
The 200-kbp tandem repeat in line NMB could be defined in more detail. NMB carried approximately 100-fold-amplified N-myc with about equal proportions of repeats 200, 280, and 490 kbp in size. About 30 copies of amplified N-myc carried a recombination that could be mapped to a position roughly 200 bp 3' to the BssHII site located in the first intron ( Fig. 6 ). When DNA digested with Notd and fractionated by PFGE was probed with Nb-1, a signal of about equal intensity was seen for the 200-, 280-, and 490-kbp fragments ( Fig. 3 ). When Nb-5 was used as a probe, the signal for the 200-kbp fragment was much fainter than that for the 280and 490-kbp fragments (Fig. 5 ). These results show that the 200-kbp tandem repeated DNA has resulted from recombination within intron I of N-myc, leading to deletion of DNA 5' of the recombination breakpoint. The novel joint connects the 5' and 3' ends of the tandemly arranged repeated DNA. We assume that the 280-and 490-kbp repeats have arisen by an identical mechanism, although the noveljoints are located more distal of N-myc. At this point we have no information about the nucleotide sequences at the novel joints.
The presence of different populations of tandem repeats found in DNA derived from the various neuroblastoma cells Nb-5 raised the question of whether there were individual cell populations each carrying a specific amplification unit or whether all cells of the tumor carried a combination of the tandem repeats. Single cell clones of lines NMB and Kelly were isolated from soft agarose and grown up, and the DNA was cut with NotI and analyzed by PFGE. We did not detect any difference in restriction pattern among four clones each of Kelly and NMB cells (data not shown). We conclude that the differently recombined populations of DNA are amplified in the same cells.
We wondered what fraction of amplified DNA could be detected with the 5' and 3' probes. Inspection of agarose gels through which DNA digested with Notl was fractionated by PFGE produced conspicuous bands upon staining with ethidium bromide. For instance, DNA from line Kelly produced bands at positions of 290, 320, and 580 kbp that could be detected by visual inspection with UV light (data not shown). Following transfer to a nylon membrane and hybridization with a mixture of 5' and 3' probes, the autoradiographs showed bands at identical positions of 290, 320, and 580 kbp (data not shown). Corresponding observations were made for other neuroblastoma cells (data not shown). This result shows that the molecular probes derived from N-myc detect at least the major portion of the amplified DNA.
N-myc copy number and amplified DNA arrangement. IMR-32 carrying approximately 25 copies of N-myc showed the most simple structure of amplified DNA (Fig. 3) . We analyzed whether the complexity and extension of amplified DNA structure correlate with the degree of amplification and have tested two additional lines, HDN-3 and NLF, carrying (N16), Kelly, NGP, and NMB were digested as indicated and hybridized with Nb-5 (5' probe). After the probe was removed, the filter was rehybridized with Nb-12 (5' probe). Sizes of fragments were estimated by comparison with lambda oligomers and yeast chromosomes. We used BssHII and MluI in addition to Notl (Fig. 7) . After digestion with NotI and BssHII, all three lines showed a 400-kbp fragment with the 5' probe and a 600-kbp fragment with the 3' probe corresponding to the normal pattern of single-copy N-myc. In HDN-3, these normal fragments amounted to 100% of the amplified DNA. The 130-kbp MluI fragment in the 5' direction was presumably due to a rare polymorphism. The 3' MluI fragment was at a size exceeding 1,300 kbp not differing from the signal in normal lymphocytes. In lines NLF and IMR-32, only twothirds of the Notl and BssHII fragments in both 5' and 3' directions appeared to be of normal size, as were the 820-kbp MluI fragments in the 5' direction. We cannot explain at this point why the major MluI fragment in the 3' direction comigrated with the NotI and BssHII fragments. It is possible that a rearrangement had occurred within that distance of 600 kbp. Alternatively, the MluI fragment could be due to a polymorphism. Altogether, these results indicate that, independent of the number of passages in culture, a low degree of amplification is correlated with simple amplified DNA struc-ture around N-myc. We conclude that the majority of amplified units of the two neuroblastoma lines IMR-32 and NLF lacked rearranged DNA over approximately 1,400 kbp encompassing N-myc and that the size of most of the amplified units in these cells is in excess of 1,400 kbp. In cell line HDN-3, we could not detect any rearrangement within about 1,500 kbp, the limit of our analytical approach. Our data indicate that a low degree of amplification is correlated to the large size and simple structure of amplified DNA. Stability of amplified DNA structure during cell passages. Recombination events resulting in rearranged DNA could have occurred very early during the amplification process. Alternatively, recombinations might be frequent events during in vitro passage of cells and result in an ever increasing heterogeneity of the amplified DNA. We questioned the stability of the amplified DNA and used three different approaches to determine it. First, we compared the structure of amplified DNA in cells taken directly from a tumor and of in vitro passage 6. Cells directly analyzed from tumor HDN-16 carried approximately 100-fold-amplified N-myc. The Cell lines with a low degree of amplification show simple structure of amplified DNA. Cell lines NLF, IMR-32, and HDN-3 (N3) with 10 to 25 copies of N-myc were digested as indicated, fractionated by PFGE, and hybridized with Nb-5 (5' probe). After the probe was removed, the filter was rehybridized with Nb-12 (3' probe). Sizes of fragments were estimated by comparison with yeast chromosomes.
minor NotI fragments between 100 and 720 kbp in size ( Fig.  8 ). An identical pattern was seen after the cells had been established in in vitro culture. Second, we passaged cells of tumor HDN-3 through several alternating culture cycles in vivo in the nude mouse and in vitro for a time period of nearly 18 months. An apparently unaltered pattern was still detectable after 15 months of in vivo and in vitro culture (data not shown). Third, we analyzed the structure of amplified DNA in neuroblastoma cell lines NMB, IMR-32, and Kelly at intervals over a period of more than 18 months with restriction endonuclease Notl and 5' and 3' probes. The later passages did not reveal a pattern of amplified DNA that was different from that of early passages. Together, our results show that the structure of the amplified DNA in neuroblastoma cells is stable over long periods of time and indicate that rearrangements within the amplified DNA, whenever detectable, had resulted from recombinations during the amplification process and not from long-term tissue culture.
Structure of amplified DNA in the vicinity of N-myc. Is rearrangement of DNA in the vicinity of N-myc a frequent event? Our experimental strategy was based on the observation that, after double digestion of total DNA from neuroblastoma lines Kelly, NGP, NMB, and IMR-32 with restriction endonucleases NotI and ClaI followed by PFGE fractionation, multiple fragments could be detected with probes Nb-1 and Nb-12 (Fig. 9 ). The complex pattern, with fragment sizes ranging from 80 to about 600 kbp, was presumably a result of partial digestion of ClaI. In all four cell lines, the 3' probe detected common 80-and 100-kbp fragments (Fig. 9 ). The larger fragments appeared to differ in size among the four lines. These results indicated to us that the 3'-flanking region is not grossly rearranged over a distance of at least 100 kbp. The corresponding approach in the 5' direction did not reveal evidence for rearrangement FIG. 9. Assessment of molecular rearrangement at the N-myc locus. DNAs of cell lines IMR-32, NGP, Kelly, and NMB were doubly digested with NotI and ClaI, fractionated by PFGE, and hybridized with Nb-1. After the probe was removed, the filter was rehybridized with Nb-12. Sizes of fragments were estimated by comparison with lambda oligomers and yeast chromosomes. over a distance of at least 110 kbp with the exception of cell line IMR-32, in which we could not detect the smallest NotI-ClaI fragment. Considering the apparently normal 5' NotI fragment seen in IMR-32, we favor the idea that lack of the smallest NotI-ClaI fragment did not indicate rearrangement but rather was due to partial sensitivity of the ClaI site. Taken together, our results show that, although in 11 of 12 neuroblastoma cell lines the amplified DNA is rearranged within 1,000 kbp encompassing N-myc, at least 4 of the lines do not show evidence of gross rearrangement over a distance of about 200 kbp around N-myc.
DISCUSSION
Structure of amplified DNA. Our structural analysis of the amplified DNA was facilitated by the identification of recognition sequences for rare cutting restriction endonucleases in the 5' region of N-myc. Additional studies (unpublished data) had revealed that the 5' region of N-myc, particularly exon II, contains multiple recognition sequences sensitive to the restriction endonuclease HpaII. These observations reveal the presence of an HTF island ("HpaII tiny fragments") containing unmethylated CpG dinucleotides) for a review, see reference 6). Although the role these islands may play in gene expression is unclear, they offer unique starting points for generating long-range maps of the vertebrate genome (for a review, see reference 4).
Our results with these restriction sites revealed that the amplified DNA encompassing N-myc in neuroblastoma cells is heterogeneous among cells derived from different tumors. In only 3 of the 12 tumors studied, IMR-32, HDN-3, and NLF, could we detect DNA fragments (for instance, with NotI and BssHII) that appeared identical in size to those seen in the 5' or 3' direction in normal lymphocytes. In no other instance were we able to identify those fragments unequivocally because most of the presumably rearranged fragments were migrating in the same size range. IMR-32, HDN-3, and NLF carry a low copy number of N-myc, and it appears possible, therefore, that a low copy number of amplified DNA is correlated with a low degree of recombination and large amplicon size.
It seems unlikely that the different fragment sizes in the various tumors are due to polymorphisms, because analyses involving different unrelated human individuals produced invariable NotI restriction patterns and the rearrangements could be detected with three different enzymes. Heterogeneity of amplified DNA in neuroblastoma cells has been found before in experiments in which random sequences were isolated from neuroblastoma line IMR-32 (14) . When used as molecular probes, many of these sequences failed to detect amplified DNA in other neuroblastoma cell lines, in contrast to probes from the N-myc locus that detected amplification in all neuroblastoma cell lines. This observation is not surprising in view of our result that in cell line IMR-32 the major proportion of amplified DNA is present without apparent rearrangement over a distance of at least 820 kbp in the 5' direction and 600 kbp in the 3' direction, as defined by recognition sites for MluI in the 5' and NotI in the 3' direction, in contrast to the majority of other cell lines in which the amplified DNA is rearranged within this 1,400-kbp region. These studies show that different portions of DNA usually flanking N-myc remain unamplified in the various neuroblastoma cell lines.
An unexpected observation was the high stability of the molecular structure of the amplified DNA. For instance, in IMR-32, DNA usually flanking N-myc spanning at least 1,400 kbp appears to have been stable through numerous cell passages since the cell line was established in culture. Further, in no case did we encounter a change in restriction pattern in cell lines during long-term culture, during establishment of cells from a tumor in tissue culture, or in the course of alternative passages of tumor cells in vitro in tissue culture and in vivo in the mouse. This stability of DNA structure is remarkable given the observations made for amplified DNA associated with drug-resistant cells. For instance, it was found (11) in cells resistant to methotrexate that there was a continual change in the structure of amplified DNA within growth periods of 6 to 24 months. Similarly, Bostock and Tyler-Smith (7) and Brison et al. (8) detected a diversity of rearrangements during continuous culture of drug-resistant cells. The basis for the different stabilities of amplified DNA in drug-resistant and neuroblastoma cells is not clear. It is possible that drug exposure or cell type influences the stability of amplified DNA.
Head-to-tail tandem repetitions. Most information about the arrangement of amplified DNA has come from studies of drug resistance genes. Following introduction of defined drug resistance genes into human cells, Roberts et al. (22) could identify an amplification gradient in which sequences centrally located were amplified to a higher degree than those at the more distal region. A regular arrangement with about 10 to 15% of the DNA arranged as a 260-kbp headto-tail tandem repeat was identified in methotrexate-resistant Chinese hamster ovary cells (19) ; the remaining major portion of the amplified DNA was arranged in a head-to-head or a tail-to-tail configuration. Homogeneous arrangement of amplified DNA in submicroscopic extrachromosomal elements in methotrexate-resistant HeLa cells was also seen by Maurer et al. (20) . In one cell variant the size of the extrachromosomal structure was determined by PFGE to be in the range of 650 kbp. Our results have shown that in human neuroblastoma cells, in spite of variability in structure, a regular pattern of arrangement of amplified DNA is prominent. For instance, in cell line NMB, three NotI, BssHII, and MluI fragments of 200, 280, and 490 kbp were detectable with molecular probes 5' and 3' of the single NotI site located in the CpG island of N-myc. This circularly permuted pattern is consistent with a head-to-tail tandem arrangement of DNA units 200, 280, and 490 kbp, respectively. With the exception of lines IMR-32, NLF, and HDN-3, in which the sizes of the amplified DNA exceeded detection with our present analytical techniques, all neuroblastoma cells revealed evidence of the presence of headto-tail tandem arrangements of varying portions of amplified DNA in addition to the DNA apparently arranged heterogeneously. In line Kelly, in which the amplified DNA was detectable on agarose gels stained with ethidium bromide, the head-to-tail rearrangements amounted to at least the major portion of the total amplified DNA in the cells, and it is unlikely that in this case there was a substantial amount of DNA in addition to that detectable with the N-myc probes.
Line NMB contains a single HSR on chromosome 13q21 to which N-myc has been localized by in situ hybridization (29) . There are two ways the 200-, 280-, and 490-kbp repeats could be spatially distributed on the HSR. It is possible that the direct repeats form discrete regions of amplified DNA in separate areas of the HSR. Alternatively, it is possible that NMB contains different populations of cells each of which carries the 200-, the 280-, or the 490-kbp repeat. Our finding of all amplified units in cell clones established from lines NMB and Kelly allow us to conclude that amplicons of different sizes are clustered in discrete regions of the single HSR within the same cell.
It is not clear at present whether there are alternative regular arrangements of amplified DNA in neuroblastomas cells in addition to the tandem repetitions. Large inverted duplications have earlier been reported from human cell lines in which myc was amplified (12) . Their technical approach did not allow identification, though, of the proportion of inverted repeats in relation to direct repeats or random arrangement. Further, inverted duplications were observed in a Chinese hamster cell line carrying the amplified adenylate deaminase gene (13) and were implicated as a primary event of gene amplification in Rat-1 cells transfected with the transforming region of polyoma virus DNA (21) . For neuroblastoma cells, we have no evidence as yet of the presence of invertedly repeated DNA. It appears, though, that inverted repeats do not predominate because, at least in NMB, the major portion of the amplified DNA encompassing N-myc is arranged as direct repetitions. N-myc may be the only gene common to all amplified populations of DNA. We have made two observations that allow us to speculate as to how many transcription units may be common to all populations of amplified DNA in neuroblastoma cells. First, the region around N-myc in the majority of neuroblastoma cells remains unaffected by recombination. The only exception is the 200-kbp tandem repeat in NMB in which a novel joint is localized within intron I, resulting in deletion of the first exon. The coding region of N-myc has remained unaltered by this recombination, however. Our results are consistent with observations by Zehn-bauer et al. (37) , who identified by cosmid walking a contiguous region around N-myc of at least 140 kbp lacking recombination in neuroblastoma line NGP and in 12 tumors. Second, the smallest unit of amplification we could identify directly by PFGE was the 100-kbp direct repeat in line HDN-16. This 100-kbp repeat sequence most likely contains only a single CpG island that is localized within the N-myc gene. Usually, the CpG islands flanking N-myc 5' and 3' appear to be 400 and 600 kbp apart, respectively, as indicated by the colocalization of Notl and BssHII sites. Accepting the hypothesis that many genes are signified by the presence of a CpG island, our studies do not indicate any additional genes localized within the 100-kbp sequence encompassing N-myc. To address this issue in more detail, we are in the process of generating molecular clones representative of the complete 100-kbp unit.
Mechanism of DNA amplification. Although an exact definition of the initial events during amplification cannot be made, a model of DNA amplification has to take into consideration the following observations made by cytogenetic and molecular genetic procedures. First, direct preparations of neuroblastoma cells have revealed only DMs as cytogenetic evidence of amplified DNA (10; S. Bruderlein, unpublished data), yet nearly all neuroblastoma cell lines established in long-term culture lack DMs and contain an HSR instead (9) . Second, amplification is associated with transposition of DNA into different chromosomal regions. N-myc is usually localized on chromosome 2p24-26 (25); HSRs carrying amplified N-myc in different neuroblastoma cell lines are localized on distant positions, usually not on chromosome 2. Third, the size of an HSR is many times that of a single DM.
As the initial step of amplification, we favor local polytenization (7) resulting from illegitimate usage of an origin of replication within a single cell cycle. The extrareplicated DNA must be excised, perhaps by a recombination, joining the extrareplicated DNA segments to yield a head-to-head or a head-to-tail circular duplication. This step of our model would be consistent with both the observation of large inverted duplications seen in certain cell systems (12, 13) and the tandem repetitions seen in the present study. It appears that, in neuroblastoma cells, recombination yielding tandem repetitions is favored. We are postulating excision of the extrareplicated DNA because in situ hybridization studies of neuroblastoma cells have failed to yield evidence of amplified DNA at the original location of N-myc on 2p24-26 (29) . Yet, studies by Kanda et al. (14) on neuroblastoma line IMR-32 suggest that DNA amplified in a large HSR on chromosome 1 is still present on chromosome 2p in what appears to be a single copy. We assume that the excised DNA can be stabilized extrachromosomally and can replicate. This assumption would be consistent with the identification of populations of extrachromosomal replicating circular DNA molecules harboring amplified myc genes (35) , although the existence of such circular elements has not been formally established in neuroblastoma cells. It is possible that the extrachromosomal DNA may occupy structures that can be visualized as DMs. The DMs obviously can survive for extended periods of time, but ultimately the DNA of at least one extrachromosomal element becomes integrated into a chromosomal region. Precedence for the mechanism is represented by Leishmania resistant to methotrexate, in which the amplified DNA is initially found extrachromosomally and is only later arranged as repetitive arrays within chromosomal DNA (5) .
The ordered head-to-tail tandem arrangement of DNA VOL. 9, 1989 4911 units within the developed HSR most likely results from an in situ amplification process, although it is difficult to generate direct experimental evidence for this assumption. We think it unlikely that multiple integrations of different extrachromosomal DNA elements in the size range of several hundred kilobase pairs can occur at the same chromosomal site to yield an ordered DNA arrangement. We cannot exclude the possibility, however, that extrachromosomal DNA can be further amplified, perhaps by a rolling-circle mechanism, to yield by recombination large contiguous DNA molecules the size of HSR DNA. In murine SEWA cells, chromosomal structures designated C-bandless chromosomes have been found that are much larger than DMs (18) and harbor amplified myc genes (27) . They apparently represent intermediary structures that develop during transitions of DMs into HSRs (18) . In neuroblastoma cells, evidence of extrachromosomal DNA in the size range of that contained in an HSR is lacking. It is clear that, in view of multiple recombinations, the generation of an ordered arrangement of amplified DNA with retention of N-myc requires strong selective forces. Previous studies have implicated N-myc in cellular growth control. Augmented expression of N-myc induces tumorigenicity in an established line of rat fibroblasts (32) , rescues rat embryo cells from senescence (26) , and can assist a mutant allele of the protooncogene H-ras in the transformation of rat embryo cells (28, 36) . Given these findings and in view of our observations that (i) the coding region of N-myc has remained unaltered in all neuroblastoma cells in spite of multiple rearrangements of the amplified DNA and (ii) Nmyc is the common denominator of at least most amplified DNA units, the results of this study lend further credence to the idea that it is the gene N-myc that is selected for from the heterogeneous populations of amplified DNA. It is likely that N-myc rather than another amplified DNA sequence contributes to tumorigenesis.
